ReviewJournal for immunotherapy of cancer2024

Biomarker development for PD-(L)1 axis inhibition: a consensus view from the SITC Biomarkers Committee.

Anne Monette et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.